Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients

References

• RouprêtMBabjukMCompératEEuropean guidelines on upper tract urothelial carcinomas: 2013 updateEur Urol20136361059107123540953
   PubMed Web of Science ®Google Scholar
• SiegelRMaJZouZJemalACancer statisticsCA Cancer J Clin2014201464929
   Google Scholar
• ShariatSFFavarettoRLGuptaAGender differences in radical nephroureterectomy for upper tract urothelial carcinomaWorld J Urol201129448148620886219
   PubMed Web of Science ®Google Scholar
• LughezzaniGSunMPerrottePGender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results databaseUrology201075232132719962727
   PubMed Web of Science ®Google Scholar
• FernándezMIShariatSFMargulisVEvidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter studyUrology200973114214618845322
   PubMed Web of Science ®Google Scholar
• XiongGChenXLiXPrevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patientsJ Formos Med Assoc2014113852152623684217
   PubMed Web of Science ®Google Scholar
• XiongGLiuJTangQPrognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinomaEpigenomics20157573374425912368
   PubMed Web of Science ®Google Scholar
• ChenXPXiongGYXsLPredictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in ChinaBJU Int201311291792423905945
   PubMed Web of Science ®Google Scholar
• FangDXiongGLiXIncidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese populationUrol Oncol201533266.e166.e11
   PubMed Web of Science ®Google Scholar
• ZhangLXiongGFangDContralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylationJ Exp Clin Cancer Res2015341525613404
   PubMedGoogle Scholar
• YcMZuoLChenJHLuoQXqYLiYet at. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney diseaseJ Am Soc Nephrol2006172937294416988059
   PubMed Web of Science ®Google Scholar
• SobinLHGospodarowiczMKWittekindCTNM Classification of Malignant TumoursHoboken, NJJohn Wiley & Sons2011
   Google Scholar
• MostofiFKSobinLHTorloniHHistological Typing of Urinary Bladder TumorsGeneva, SwitzerlandWorld Health Organization1973
   Google Scholar
• MclaughlinJKSilvermanDTHsingAWCigarette smoking and cancers of the renal pelvis and ureterCancer Res1992522542571728398
   PubMed Web of Science ®Google Scholar
• ColinPKoenigPOuzzaneAEnvironmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tractBJU Int2009104101436144019689473
   PubMed Web of Science ®Google Scholar
• ShinkaTMiyaiMSawadaYInagakiTOkawaTFactors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic aminesInt J Urol1995242432488564742
   PubMedGoogle Scholar
• GrollmanAPShibutaniSMoriyaMAristolochic acid and the etiology of endemic (Balkan) nephropathyProc Natl Acad Sci200710429121291213417620607
   PubMed Web of Science ®Google Scholar
• ChenCHDickmanKGMoriyaMAristolochic acid-associated urothelial cancer in TaiwanProc Natl Acad Sci U S A2012109218241824622493262
   PubMed Web of Science ®Google Scholar
• ArltVMStiborovaMSchmeiserHHAristolochic acid as a probable human cancer hazard in herbal remedies: a reviewMutagenesis200217426527712110620
   PubMed Web of Science ®Google Scholar
• LordGMHollsteinMArltVMDNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathyAm J Kidney Dis2004434e11e17
   PubMed Web of Science ®Google Scholar
• AttaluriSBonalaRRYangIYDNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cellsNucleic Acids Res201038133935219854934
   PubMed Web of Science ®Google Scholar
• PoonSLPangSTMcphersonJRGenome-wide mutational signatures of aristolochic acid and its application as a screening toolSci Transl Med20135197:ra101
   Web of Science ®Google Scholar
• HoangMLChenCHSidorenkoVSMutational signature of aristolochic acid exposure as revealed by whole-exome sequencingSci Transl Med20135197ra102
   Web of Science ®Google Scholar
• NortierJLMartinezMCSchmeiserHHUrothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)N Engl J Med2000342231686169210841870
   PubMed Web of Science ®Google Scholar
• PozdzikAABertonASchmeiserHHAristolochic acid nephropathy revisited: a place for innate and adaptive immunity?Histopathology201056444946320459552
   PubMed Web of Science ®Google Scholar
• YangLSuTLiXMAristolochic acid nephropathy: variation in presentation and prognosisNephrol Dial Transplant201227129229821719716
   PubMed Web of Science ®Google Scholar
• CukuranovicRIgnjatovicIVisnjicMCharacteristics of upper urothelial carcinoma in an area of Balkan endemic nephropathy in south Serbia. A fifty-year retrospective studyTumori201096567467921302610
   PubMed Web of Science ®Google Scholar
• FangDZhangLLiXRisk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese centerJ Cancer Res Clin Oncol2014140347748524469253
   PubMed Web of Science ®Google Scholar
• YangLSuTLiXMAristolochic acid nephropathy: variation in presentation and prognosisNephrol Dial Transplant201227129229821719716
   PubMed Web of Science ®Google Scholar
• FangDLiuPLiXCharacteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patientsSci Rep20165118014
   Google Scholar
• China statistical yearbook of health and family planning, version2013 Available from: http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.htmlAccessed December 13, 2015
   Google Scholar